WI Biohealth Investor Portfolio Report
BioForward proudly presents the BioForward Wisconsin’s inaugural WI Biohealth Investor Portfolio Report, highlighting the funding wins and milestone achievements of biohealth companies across our state....
BioForward proudly presents the BioForward Wisconsin’s inaugural WI Biohealth Investor Portfolio Report, highlighting the funding wins and milestone achievements of biohealth companies across our state....
The prospective, head-to-head trial demonstrated that the company’s Oncoguard® Liver blood test delivers superior early-stage and overall sensitivity for hepatocellular carcinoma (HCC) — the most common form of liver cancer — compared to the current standard of care....
The UW–Madison and the Morgridge Institute for Research have built a nexus of researchers who are pushing biological optical microscopy — including and beyond fluorescence — at all of its edges. Working together and with collaborators across the globe, these labs are engineering transformative label-free...
Speaking at WTC Early Stage Symposium in Madison during her third day on the job, Brickerman discussed how her past work with startup accelerator gener8tor will shape her approach to leading the organization....
Milwaukee developer Mandel Group announced Tuesday it has completed assembling a $65 million financing package to construct Element Collective, a 197-unit workforce housing development located in University Research Park....
Innovators from across the state gathered Tuesday at Monona Terrace Community and Convention Center as the Wisconsin Technology Council presented the 2025 Wisconsin Innovation Awards....
Patrick Tetzlaff and Brian Leadingham, run Design Department, Inc., a Franklin-based product development consultancy. The team will present the spherical canister during the Elevator Pitch Olympics, part of the Early Stage Symposium presented by the WTC....
Sahab Aslam, founder of Vectorify Labs and the AI sector lead at the Harvard Business School Alumni Angels of New York, was a featured speaker during yesterday’s WTC luncheon in Madison....
EMP-012’s novel mechanism of action, discovered by Empirico, targets a distinct inflammatory pathway introducing the potential for a therapeutic approach that is agnostic of baseline type 2 inflammation, smoking or co-morbid disease. ...
Prof. Burgess, Senior Oncology Advisor to FAR Biotech, is the James D. Watson Professor Emeritus of Oncology at UW–Madison’s McArdle Laboratory for Cancer Research....